March 4, 2020 / 1:10 PM / a month ago

BRIEF-Lipocine Says FDA Has Assigned A Prescription Drug User Fee Act Goal Date Of August 28, 2020 For TLANDO

March 4 (Reuters) - Lipocine Inc:

* LIPOCINE ANNOUNCES TLANDO™ PDUFA DATE OF AUGUST 28, 2020

* LIPOCINE INC - FDA HAS ASSIGNED A PRESCRIPTION DRUG USER FEE ACT GOAL DATE OF AUGUST 28, 2020 FOR TLANDO Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below